UC HEALTH LINE: Chronic Fatigue Sufferers Need More Than Just Rest
Chronic fatigue syndromedefined by the Centers for Disease Control and Prevention (CDC) as extreme fatigue lasting at least six monthscan affect anyone no matter what age or gender, but is four times more common in women.
Lesley Arnold, MD, director of UCs Womens Health Research Program, treats chronic fatigue and conducts clinical trials using medications that may improve symptoms for those suffering from this often debilitating condition.
And,
We dont know what causes chronic fatigue, says
What we do know is that the majority of people with chronic fatigue go undiagnosed.
For anyone who thinks they may have chronic fatigue,
Medications, combined with non-drug therapies, such as stress reduction and improved diet, can help relieve symptoms of chronic fatigue,
For more information about the chronic fatigue research program and to learn about current clinical trials, call (513) 475-8113. To learn more about the Womens
Tags
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
Bidirectional link between oral, kidney health calls for patient education, access
August 4, 2026
Despite growing awareness of the connection between oral health and chronic health conditions, patient awareness and access to dental care remain limited, according to University of Cincinnati experts who recently spoke with Healio | Nephrology News & Issues.